ISMPP Highlights
Shining a Light on the ISMPP U Committee
While the ISMPP University (ISMPP U) webinars are recognized by many association members, what the ISMPP U Committee is and how an ISMPP U comes to fruition may be less well-known. This Committee Spotlight will shine some light on these aspects and how you can be part of an ISMPP U…
ISMPP Member Publications and Presentations
ISMPP is pleased to share these recent publications and presentations by Society members. We encourage members to publish and present research and information related to publishing practices to advance the medical publications profession, and improve standards and best practices…
Asia Pacific Meeting of ISMPP: An Important Regional Achievement
The second Asia Pacific Meeting of ISMPP, held September 5, 2017, in Tokyo, Japan, was attended by over 125 individuals from 10 countries. Attendees represented a diverse group, including the pharmaceutical industry, medical communication companies, academia, journal editors/publishers, and government…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Leveraging External Insights in Publication Planning
In today’s world, the need for pharmaceutical companies to quickly publish and disseminate their data is higher than ever. And, although fast is fine, accuracy is everything. As we rush forward, we need to ensure that publication planning goes beyond just dissemination of data. Instead, it should…
Embracing Change in Medical Publishing: The Open Pharma Project
Do pharmaceutical companies have a role in helping advance the publication of science? This was the question posed by Richard Smith, Former Editor of The BMJ and now Chairman for the Board of Directors of Patients Know Best, at an international meeting held at the Wellcome Trust in London earlier this year…
From Reviews to In-Silico Trials: An Overview of the Publication Landscape
In the current publication landscape, medical writers and other publication professionals need to distinguish and identify the key elements that go into the various types of reviews and analyses. This article will provide an overview of review articles, meta-analyses, and computer modeling, such as in-silico trials, and how they apply to the publication landscape…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: The Authorship Order Dilemma
You are a company medical publication professional. The publication steering committee of a company-sponsored pivotal phase 3 clinical trial has selected investigators to serve as authors, but the committee and authors are having difficulty in deciding the order of authorship. During discussions, multiple authors believe that they have equal rights to the first author position based on their contributions. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals